Neu: Nutzen Sie neue Funktionen auf als Erstes - hier informieren!
19.05.2022 13:09

The Zacks Analyst Blog Highlights Alibaba, McDonald, Advanced Micro Devices, Abbott Laboratories, and Vertex Pharmaceuticals

For Immediate ReleaseChicago, IL – May 19, 2022 – announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include:Alibaba Group Holding Ltd. BABA, McDonald's Corp. MCD, Advanced Micro Devices, Inc. AMDAbbott Laboratories ABT, and Vertex Pharmaceuticals Inc. VRTX.Here are highlights from Wednesday’s Analyst Blog:Top Stock Reports for Alibaba, McDonald's and AMDThe Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Alibaba Group Holding Ltd., McDonald's Corp., and Advanced Micro Devices, Inc.. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today. You can see all of today's research reports here >>> Alibaba shares have declined -27.3% in the year-to-date period, inline with the Zacks Tech sector's performance and better than Amazon's -33.5% decline. The uncertain outlook for Alibaba's home market given China's zero-Covid policy is exacerbating sentiment shifts in the market against growth stocks in a rising interest rate environment. While these are reasonable worries and they could very well weigh on the stock some more, the company's competitive position in the Chinese market has never been stronger. Further, its robust New Retail strategy which is gaining strong traction in the market remains a major positive. This is aiding growth in Tmall Import, Freshippo and Intime Department Stores. Furthermore, well-performing Cainiao logistics services are contributing well. Additionally, the company's strengthening cloud business on the back of its expanding customer base continues to drive its performance. (You can read the full research report on Alibaba here >>>) Shares of McDonald's have outperformed the Zacks Retail - Restaurants industry over the past year (+4.4% vs. -16.8%) on the back of robust comps growth. The Zacks analyst believes that the strong drive-thru presence and its investments in delivery and digitization over the past few years have aided McDonald's in countering the pandemic. Robust digitalization will help the company in driving long-term growth and capturing market share. The company is focusing on store expansion efforts. It is planning to open more than 1,800 restaurants globally in 2022. However, coronavirus-related woes persist. In first-quarter 2022, comps in the China market were hurt by the pandemic. (You can read the full research report on McDonald's here >>>) Shares of Advanced Micro Devices have outperformed the Zacks Electronics - Semiconductors industry over the past year (+34.5% vs. +25.2%). The Zacks analyst believes that the company is benefiting from the strong demand of its Ryzen and EPYC server processors, owing to the increasing proliferation of Artificial Intelligence (AI) and Machine Learning (ML) in industries like cloud, gaming and data center. The growing clout of 7 nanometer (nm) products in the data center vertical, driven by work-from-home and online learning trends, is a key catalyst. AMD provided strong 2022 guidance for revenues backed by robust growth across all businesses. Higher server and client processor revenues are likely to lead to a sequential increase. The Xilinx and Pensando acquisition will boost AMD's data center business. Alliances with Amazon, Microsoft, Baidu and augment business prospects. However, stiff competition from NVIDIA and Intel is a concern. (You can read the full research report on Advanced Micro Devices here >>>) Other noteworthy reports we are featuring today include Abbott Laboratories, and Vertex Pharmaceuticals Inc.Why Haven't You Looked at Zacks' Top Stocks? Our 5 best-performing strategies have blown away the S&P's impressive +28.8% gain in 2021. Amazingly, they soared +40.3%, +48.2%, +67.6%, +94.4%, and +95.3%. Today you can access their live picks without cost or obligation.See Stocks Free >>Zacks Investment Research800-767-3771 ext.                                                                             Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit for information about the performance numbers displayed in this press release.7 Best Stocks for the Next 30 DaysJust released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."Since 1988, the full list has beaten the market more than 2X over with an average gain of +25.4% per year. So be sure to give these hand-picked 7 your immediate attention. See them now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Abbott Laboratories (ABT): Free Stock Analysis Report Advanced Micro Devices, Inc. (AMD): Free Stock Analysis Report McDonald's Corporation (MCD): Free Stock Analysis Report Vertex Pharmaceuticals Incorporated (VRTX): Free Stock Analysis Report Alibaba Group Holding Limited (BABA): Free Stock Analysis Report To read this article on click here. Zacks Investment Research
Weiter zum vollständigen Artikel bei "Zacks"
Ausgewählte Hebelprodukte auf Abbott Laboratories
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Abbott Laboratories
Hebel wählen:
Quelle: Zacks

Nachrichten zu Alibaba

  • Relevant
  • Alle
  • vom Unternehmen
  • Peer Group
  • ?

Um Ihnen die Übersicht über die große Anzahl an Nachrichten, die jeden Tag für ein Unternehmen erscheinen, etwas zu erleichtern, haben wir den Nachrichtenfeed in folgende Kategorien aufgeteilt:

Relevant: Nachrichten von ausgesuchten Quellen, die sich im Speziellen mit diesem Unternehmen befassen

Alle: Alle Nachrichten, die dieses Unternehmen betreffen. Z.B. auch Marktberichte die außerdem auch andere Unternehmen betreffen

vom Unternehmen: Nachrichten und Adhoc-Meldungen, die vom Unternehmen selbst veröffentlicht werden

Peer Group: Nachrichten von Unternehmen, die zur Peer Group gehören

Analysen zu Alibaba

  • Alle
  • Buy
  • Hold
  • Sell
  • ?
05.11.2020Alibaba kaufenDZ BANK
16.05.2019Alibaba BuyThe Benchmark Company
31.01.2019Alibaba OverweightBarclays Capital
12.11.2018Alibaba Conviction Buy ListGoldman Sachs Group Inc.
05.11.2018Alibaba BuyThe Benchmark Company
05.11.2020Alibaba kaufenDZ BANK
16.05.2019Alibaba BuyThe Benchmark Company
31.01.2019Alibaba OverweightBarclays Capital
12.11.2018Alibaba Conviction Buy ListGoldman Sachs Group Inc.
05.11.2018Alibaba BuyThe Benchmark Company
25.01.2017Alibaba NeutralWedbush Morgan Securities Inc.
09.01.2017Alibaba AccumulateStandpoint Research
29.10.2015Alibaba HoldStandpoint Research
06.05.2015Alibaba HoldT.H. Capital
23.02.2012Alibabacom neutralNomura
20.04.2017Alibaba ReduceStandpoint Research
02.12.2011Alibabacom reduceNomura
25.11.2011Alibabacom reduceNomura
27.09.2011Alibabacom underperformMacquarie Research
12.08.2011Alibabacom underperformMacquarie Research

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Alibaba nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"

Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"

Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen
Neue Funktionen als Erstes nutzen
Sie nutzen regelmäßig? Dann nutzen Sie jetzt neue Funktionen als Erstes!
Hier informieren!
Börse Stuttgart Anlegerclub

Heute im Fokus

Ukraine-Krieg im Ticker: DAX geht etwas fester ins Wochenende -- US-Börsen schließen stark-- Siemens nimmt Milliarden-Abschreibung auf Siemens Energy vor -- Commerzbank, TUI, JENOPTIK, BMW im Fokus

BMW: Empfindlicher Dämpfer bei US-Verkäufen. USA bestellt erneut Affenpocken-Impfstoff bei Bavarian Nordic. Porsche setzt in den USA im zweiten Quartal mehr Autos ab. Salmonellen-Schokolade von Barry Callebaut ist nicht in Läden gelangt. BASF und MAN wollen gemeinsam riesige Wärmepumpe in Ludwigshafen bauen.

Die 5 beliebtesten Top-Rankings

mehr Top Rankings


Goldpreis im Fokus der Anleger: Sind Sie in Gold investiert? zero zero



Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
Zur klassischen Ansicht wechseln